<script> window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'UA-48293608-1'); </script>
Logo-bi
Bioimpacts. 2025;15: 32630 | Published on: 2025 Dec 14. doi: 10.34172/bi.32630
PMID: 41716515        PMCID: PMC12913208

Review

Targeted therapy for liver cancer: Current status and future directions

Qian Wang 1 * ORCID

Cited by CrossRef: 0

1- Ponomarchuk E, Tsysar S, Sapozhnikov O, Kvashennikova A, Pestova P, Chupova D, Papikyan L, Nartov F, Bashmashnikova A, Kadrev A, Kamalov A, Sotnikova T, Grachalov A, Ivashov I, Khorobrykh T, Danilova N, Malkov P, Buravkov S, Khokhlova V. Boiling Histotripsy Ex Vivo in Human Liver Metastases of Various Origin. Ultrasound in Medicine & Biology. 2026; [Crossref]
2- Liu X, Gao X, Yang Y, Yang D, Sun Y, Yang Y, Zhao T, Li N. Unraveling regorafenib resistance: metabolic reprogramming, tumor plasticity, and novel approaches to overcome therapy failure. Arch Pharm Res. 2026;49(4):475 [Crossref]

Poster

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate (2024): 19% 
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded; Google Scholar;   SJR; Essential Science Indicators; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO
Member of   
Follower of ICMJE
Permission: Creative Commons